South San Francisco, California Saturday, July 19, 2025, 14:00 Hrs [IST] ...

US FDA accepts resubmitted NDA of Aldeyra Therapeutics for review of topical ocular reproxalap to treat dry eye disease: Lexington, Massachusetts Saturday, July 19, 2025, 13:00 Hr ...

Seongnam, South Korea Saturday, July 19, 2025, 12:00 Hrs [IST] ...

Sanofi, an R&D driven, AI-powered biopharma company, announces the completion of its acquisition of Blueprint Medicines Corporation (Blueprint), adding to its portfolio a commercialized medicine, a ...

PCI asks State Councils to submit consolidated data of pharmacists for HPR: Our Bureau, New Delhi Saturday, July 19, 2025, 08 ...

Indian MedTech industry’s focus on innovation laying foundation for long-term self-reliance: Nandita Vijaysimha, Bengaluru Saturday, July 19, 2025, 08:00 Hrs [IST] India’s med ...

TN chief minister to distribute appointment orders to 17 new drug inspectors: Peethaambaran Kunnathoor, Chennai Saturday, July 19, 2025, 08:00 Hrs [IST] In a significant move to f ...

LUB raises various concerns and demands related to pharma industry: Our Bureau, New Delhi Saturday, July 19, 2025, 08:00 Hrs [IST] Laghu Udyog Bharati (LUB), the association repre ...

Applications invited for Pharmexcil Awards for outstanding export performance in FY 2023–24: Shardul Nautiyal, Mumbai Saturday, July 19, 2025, 08:00 Hrs [IST] The Pharmaceutical ...

US FDA lifts clinical hold on PORTOLA phase 2a trial of Kezar Life Sciences for evaluating zetomipzomib to treat autoimmune hepatitis: South San Francisco, California Friday, July ...

Miltenyi Biotec and THSTI FIVE partner to launch India’s first hands-on CAR-T cell and gene therapy training curriculum: Our ...

Nicox & Kowa ink agreement worth up to €191.5 mn for exclusive rights to glaucoma treatment NCX 470 in US and all unlicensed territories: Sophia Antipolis, France Friday, July 1 ...